Tara C Fleis Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 308 Cleveland Ave Ste 114, Ishpeming, MI 49849 Phone: 906-282-3130 Fax: 906-323-4215 |
Northern Star Counseling Services, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 308 Cleveland Ave Ste 311, Ishpeming, MI 49849 Phone: 906-362-4174 |
Great Lakes Recovery Centers Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 97 S. 4th Street, Suite C, Ishpeming, MI 49849 Phone: 906-228-9699 Fax: 906-228-0505 |
Paul Olson Counseling Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 308 Cleveland Ave Ste 302, Ishpeming, MI 49849 Phone: 906-362-1491 |
Dba Karen Duquette, Phd Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 540 E Division St, Ishpeming, MI 49849 Phone: 906-486-6860 |
News Archive
In continuing efforts to find novel ways to kill cancer cells, researchers at the University of Maryland School of Medicine have identified a new pathway that leads to the destruction of cancer cells.
Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.
Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.
A University of Central Florida cancer researcher has discovered a way to kill spreading breast cancer cells and her new technology has generated a licensing agreement that will accelerate the therapy's path to clinical trials.
› Verified 6 days ago